Jinyu Xiang

4PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Te mātauranga reo Māori (Māori language education)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 15, 2025
Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study.

Jinyu Xiang, Ping Sun, Zeyu Liu

|Oct 31, 2025
Real-World Efficacy of Cadonilimab Plus Chemotherapy as Second-Line Therapy in Immunotherapy-Pretreated Advanced HER2 Negative Gastric or Gastroesophageal Junction Cancer.

Zeyu Liu, Yuxiao Lu, Ming Li

|Mar 28, 2024
Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases.

Congcong Wang, Jinyu Xiang, Qingyu Zhang

|May 03, 2016
Silencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells.

Jianping Xiang, Shifeng Guo, Shuling Jiang

Pageof 1

Frequent Collaborators

1 joint publications

Jianping Xiang

1 joint publications

Shifeng Guo

1 joint publications

Shuling Jiang

1 joint publications

Yuelong Xu